ACE-031 (ActRIIB-IgG1)

ActRIIB-IgG1 · Acceleron Pharma, Inc. (a subsidiary of Merck & Co.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACE-031 (ActRIIB-IgG1), covering 2009-07-14 to 2009-07-14. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers [Phase 1]

See pricing